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Physical and Functional Association of LFA-1
with DNAM-1 Adhesion Molecule
The b2 integrin adhesion molecules are composed of a
common b chain (CD18) that noncovalently associates
with a subunits, including leukocyte function±associated
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inactive form of LFA-1. Once leukocytes are activated,
for instance through the T cell antigen receptor (TCR)Whereas ligation of the DNAM-1 adhesion molecule
upon recognition of a peptide antigen or by phorbol 12-triggers cytotoxicity mediated by normal NK and T
myristate 13-acetate (PMA), intracellular signals (re-cells, this function was defective in NK cell clones
ferred to as ªinside-outº signals) cause a conformationalfrom leukocyte adhesion deficiency syndrome. How-
change in LFA-1, resulting in intercellular binding andever, genetic reconstitution of cell surface expres-
effector cell function (Dustin and Springer, 1989; vansion of LFA-1 restored the ability of DNAM-1 to initiate
Kooyk et al., 1989). The cytoplasmic regulatory protein,anti-DNAM-1 mAb-induced cytotoxicity, indicating a
cytohesin, is a key molecule involved in this processfunctional relationship between DNAM-1 and LFA-1.
(Kolanus et al., 1996).Further studies demonstrated that LFA-1 physically
Antibody cross-linking of cell surface LFA-1 inducesassociates with DNAM-1 in NK cells and anti-CD3 mAb
intracellular signals (referred to as ªoutside-inº signals)stimulated T cells, for which serine phosphorylation
(Kanner et al., 1993; Arroyo et al., 1994), suggesting thatof DNAM-1 plays a critical role. In addition, cross-
ligand binding may also affect cellular functions suchlinking of LFA-1 induces tyrosine phosphorylation of
as apoptosis, cytotoxicity, proliferation, cytokine pro-DNAM-1, for which the Fyn protein tyrosine kinase is
duction, and antigen presentation (Springer, 1990; Moyresponsible. These results indicate that DNAM-1 is
and Brian, 1992; Koopman et al., 1994). Blocking theinvolved in the LFA-1-mediated intracellular signals.
interaction between LFA-1 and its ICAM ligands induces
tolerance against cardiac allografts in mice (Isobe et al.,
Introduction 1992), and studies using mice with disrupted CD11a or
CD18 genes have indicated a requirement for LFA-1 in
During a successful cellular response, several families of T cell proliferation induced by the TCR/CD3 complex
adhesion molecules participate not only in intercellular (Schmits et al., 1996; Scharffetter-Kochanek et al., 1998).
binding but also in signal transduction for effector cell These observations indicate that LFA-1 not only medi-
activation or deactivation (Springer, 1990; Dustin and ates intercellular binding but also may deliver costim-
Springer, 1991; Hynes, 1992; Hogg and Landis, 1993). ulatory signals in T lymphocytes. In contrast with
ªinside-outº signaling, little is known about the intracel-
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(NK) cells, and monocytes (Shibuya et al., 1996). De- p150/95 (CD11c/CD18) (Figure 1A). Although the precise
mechanism is unclear, the dominant expression ofpending on the experimental conditions, monoclonal an-
tibodies against DNAM-1 can function as agonists, trig- LFA-1 was also observed in the previous report after
retrovirus-mediated CD18 gene transfer in LAD cellsgering NK or T cell±mediated cytotoxicity and cytokine
production, or as antagonists, blocking NK or T cell (Bauer et al., 1998). As demonstrated in Figure 1B, ge-
netic transfer of CD18 into the LAD NK cell clone com-responses against target cells expressing a putative
DNAM-1 ligand (Shibuya et al., 1996). Upon mAb cross- pletely restored anti-DNAM-1 mAb-induced cytotoxicity
against P815 target cells. CD18 was responsible for thislinking, tyrosine residues in the cytoplasmic domain of
DNAM-1 are phosphorylated (Shibuya et al., 1996), sug- function because the anti-DNAM-1 mAb-induced killing
mediated by the reconstituted LAD NK clone, as wellgesting that DNAM-1 transduces an activation signal.
In this study, we report deficient DNAM-1 function in as normal NK cells, was prevented in the presence of
F(ab9)2 fragments of anti-CD18 mAb.NK cells from a LAD patient and explore the relationship
between LFA-1 and DNAM-1 signaling. Our prior observations demonstrated that coculture
of normal NK clones or T clones with anti-DNAM-1 mAb-
precoated P815 target cells resulted in tyrosine phos-Results
phorylation of DNAM-1 (Shibuya et al., 1996). DNAM-1
phosphorylation was completely inhibited in the pres-Defective DNAM-1 Function in NK Cells Obtained
ence of F(ab9)2 fragments of anti-CD18 (not shown). Ty-from a Patient with Leukocyte Adhesion Deficiency
rosine phosphorylation of DNAM-1 was not inducedmAbs against CD2 and CD16 are able to trigger cytolytic
by coculture of the LAD NK clones with anti-DNAM-1activity when NK cells are cocultured with target cells
mAb-precoated P815 cells (Figure 1C). However, recon-expressing Fc receptors (Schmidt et al., 1985; Siliciano
stitution of LFA-1 expression on the LAD NK clone byet al., 1985). Similarly, anti-DNAM-1 mAb is capable of
CD18 gene transfer restored the DNAM-1 tyrosine phos-inducing redirected cytolysis of Fc receptor±bearing
phorylation induced by coculture with anti-DNAM-1-mouse mastocytoma P815 mediated by CTL and NK
precoated P815 target cells. Again, this was completelyclones (Shibuya et al., 1996). P815 cells express a murine
inhibited in the presence of F(ab9)2 fragments of anti-ICAM that interacts with LFA-1 on human T and NK cells
CD18 (Figure 1C). These results indicate a functional(Cayabyab et al., 1994), suggesting that LFA-1 might be
relationship between LFA-1 and DNAM-1.involved in anti-DNAM-1 mAb-induced cytolysis against
P815.
To investigate the involvement of LFA-1 in anti-DNAM-1 LFA-1 Physically Associates with DNAM-1
mAb-induced cytolysis, NK clones were established in NK Cells
from the peripheral blood of a patient with LAD (Ander- The functional relationship between LFA-1 and DNAM-1
son and Springer, 1987). The NK clones expressed nor- led us to examine whether DNAM-1 physically associ-
mal levels of CD2, CD16, CD56, and DNAM-1 antigens ates with b2 integrins. The CD18-reconstituted LAD NK
(not shown), but completely lacked the expressions of clones expressed LFA-1 (CD11a/CD18), but not sub-
the b2 integrins LFA-1 (CD11a/CD18), MAC-1 (CD11b/ stantial levels of either Mac-1 (CD11b/CD18) or p150/
CD18), and p150/95 (CD11c/CD18) (Figure 1A). While 95 (CD11c/CD18). By contrast, normal peripheral blood
these NK cell clones demonstrated normal cytolytic ac- NK cells express all these b2 integrins (not shown) (Ti-
tivity against certain tumor cell targets, such as K562, monen et al., 1988). NK cells isolated from the peripheral
we observed that unlike NK clones from healthy donors, blood of a healthy individual were lysed in 1% digitonin
they were unable to mediate antibody-redirected cyto- buffer and immunoprecipitated with anti-CD18, anti-
toxicity against Fc receptor±bearing targets (e.g., P815) CD11a, anti-CD11b, or anti-CD11c, and the isolated
in the presence of anti-DNAM-1 mAb (Figure 1B). This proteins were analyzed by immunoblotting with anti-
deficiency was selective for DNAM-1 because antibody- DNAM-1 mAb. As demonstrated in Figure 2, DNAM-1
redirected killing triggered by mAbs against other acti- was coimmunoprecipitated with CD11a and CD18, but
vating NK cell surface receptors, for example CD16 (Fig- not CD11b or CD11c, suggesting that DNAM-1 associ-
ure 1B) or CD2 (not shown), was normal. This finding ates preferentially with the CD11a a chain or the CD11a/
suggested that DNAM-1-mediated cytolysis by the LAD CD18 heterodimer.
NK clones may require the participation of LFA-1, either
for effector±target cell adhesion or signaling.
Although the loss of b2 integrin expression in LAD CD3 Stimulation of T Cell Induces Association
of LFA-1 with DNAM-1disease is attributed to heterogeneous defects in the
common b subunit CD18 (Anderson and Springer, 1987), Anti-DNAM-1 mAb can trigger cytotoxicity mediated by
CTL as well as NK cells (Shibuya et al., 1996); however,CD18 gene transfer restores the expression and function
of LFA-1 regardless of the site of the molecular defect anti-DNAM-1 mAb does not induce cytotoxicity medi-
ated by resting T cells without prior in vitro activation(Hibbs et al., 1990; Bauer et al., 1998). To examine the
requirement of LFA-1 for anti-DNAM-1 mAb-induced cy- (not shown), raising the issue of whether DNAM-1 and
LFA-1 associate in activated, but not resting, T cells.tolysis by NK cells, we infected a LAD NK cell clone with
an amphotropic retrovirus containing a wild-type CD18 Resting T cells separated from the peripheral blood of
healthy donors were lysed in digitonin buffer and immu-cDNA. These retrovirus-transduced NK cells stably ex-
pressed LFA-1 (CD11a/CD18) at a level comparable to noprecipitated with anti-CD18 mAb. Strikingly, DNAM-1
did not coimmunoprecipitate with LFA-1 using lysatesNK cells from healthy individuals (not shown), but these
cells did not express either Mac-1 (CD11b/CD18) or prepared from resting T cells (Figure 3A). Since antigen
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Figure 1. NK Cell Clones from LAD Patients Are Deficient in Anti-DNAM-1-Induced Cell-Mediated Cytotoxicity
(A) CD32CD561 NK clones were established from a patient with leukocyte adhesion deficiency (LAD). The LAD NK clones lacked the expression
of CD11a, CD11b, CD11c, and CD18 (i.e., LFA-1, Mac-1, and p150/95) (left). The CD18 cDNA was introduced in the LAD NK clone using an
amphotropic retrovirus and NK cells stably expressing cell surface LFA-1 were sorted by flow cytometry and expanded. Genetic transfer of
CD18 into the LAD NK clone restored the expression of CD11a and CD18 (i.e., LFA-1), but these cells did not express CD11b or CD11c (i.e.,
MAC-1 and p150/95) (right).
(B) NK clones from a healthy donor killed the Fc receptor-bearing P815 target in the presence of anti-DNAM-1 mAb (left). LAD NK cell clones
killed the P815 target in the presence of anti-CD16 mAb, but not anti-DNAM-1 mAb (center). CD18 gene transfer into the LAD NK clone
restored anti-DNAM-1 mAb-induced cytolysis. Anti-DNAM-1-induced killing was inhibited in the presence of F(ab9)2 fragments of anti-CD18
mAb (left and right).
(C) The LAD NK clone lacking the expression of LFA-1 (left) or the LAD NK clone expressing LFA-1 after CD18 gene transfer (right) was
incubated for 2 min with P815 cells precoated with each mAb indicated. Cells were then lysed in 1% NP-40 buffer and immunoprecipitated
with anti-DNAM-1. The immunoprecipitates were analyzed by immunoblot using anti-phosphotyrosine (4G10) (upper) or anti-DNAM-1 mAb
(lower). Tyrosine phosphorylation of DNAM-1 was not induced in the LAD NK clone (left), but was observed in the LAD clone expressing
LFA-1 (right). The tyrosine phosphorylation of DNAM-1 in the CD18-reconstituted LAD NK cell clone was abolished in the presence of F(ab9)2
fragments of anti-CD18 mAb (right).
binding by TCR or stimulation with anti-CD3 mAb in- was coimmunoprecipitated with LFA-1 upon stimulation
of resting T cells with PMA in the absence of anti-CD3duces a conformational change of LFA-1 (Dustin and
Springer, 1989; van Kooyk et al., 1989), we examined mAb (Figure 3A). Prior studies have shown that activa-
tion of PKC causes serine phosphorylation of DNAM-1whether anti-CD3 mAb induces association of LFA-1
with DNAM-1. As demonstrated in Figure 3A, after T cell on residue 329 in the cytoplasmic domain and that S329
phosphorylation of DNAM-1 increases its ligand bindingstimulation with anti-CD3 mAb DNAM-1 was coimmuno-
precipitated with LFA-1. The anti-CD3-induced associa- activity (Shibuya et al., 1998). Therefore, resting T cells
were metabolically labeled with [32P]orthophosphate,tion of LFA-1 and DNAM-1 was prevented in the pres-
ence of a specific inhibitor of PKC (Figure 3A). In support stimulated with anti-CD3 mAb or PMA, lysed, and immu-
noprecipitated with anti-DNAM-1 mAb. As shown in Fig-of the concept that PKC activation is required for LFA-1
association with DNAM-1, we observed that DNAM-1 ure 3B, treatment of resting T cells with either anti-CD3
mAb or PMA resulted in phosphorylation of DNAM-1,
suggesting that phosphorylation may play an important
role in the association of DNAM-1 with LFA-1. By con-
trast, stimulation with pervanadate did not induce or
increase the association of LFA-1 with DNAM-1 in rest-
ing or anti-CD3-activated T cells, respectively (Figure
3C), indicating that tyrosine phosphorylation of DNAM-1
or LFA-1 may not be required for this interaction.
Figure 2. Association of LFA-1 with DNAM-1 in Peripheral NK Cells S329 of DNAM-1 Plays a Critical Role for the Association
Resting peripheral blood CD32CD561 NK cells were lysed in 1% of LFA-1 with DNAM-1 in T Cells
digitonin buffer and immunoprecipitated (IP) with control Ig, anti- Unlike the situation with resting T cells, DNAM-1 was
CD18, CD11a, CD11b, CD11c, or anti-DNAM-1. The immunoprecipi-
coimmunoprecipitated with LFA-1 in lysates preparedtates were analyzed by immunoblotting (IB) with anti-DNAM-1 mAb.
from the human T and NK cell leukemias Jurkat andDNAM-1 was coimmunoprecipitated with CD11a and CD18, but not
with CD11b and CD11c. NKL, respectively (Figure 4A), as well as from freshly
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Figure 3. Anti-CD3- or PMA-Induced Association of LFA-1 with DNAM-1 in Peripheral T Cells
(A) Resting peripheral blood T cells were stimulated with plastic-coated cIg or anti-CD3 mAb for 2 min in the presence or absence of the PKC
inhibitor GF109203X (1 mM), or PMA (50 ng/ml) at 378C for 2 hr. The cells were lysed in 1% digitonin buffer and immunoprecipitated with anti-
CD18 mAb or control Ig. The immunoprecipitates were analyzed by immunoblotting with anti-DNAM-1 mAb. CD18 coimmunoprecipitates
DNAM-1 in T cells activated by anti-CD3 or PMA.
(B) Resting peripheral T cells were metabolically labeled with [32P]orthophosphate; stimulated with cIg, anti-CD3 mAb, or PMA; lysed; and
immunoprecipitated with anti-DNAM-1 mAb. Treatment of resting T cells with either anti-CD3 mAb or PMA resulted in phosphorylation of
DNAM-1.
(C) Resting peripheral blood T cells were stimulated with plastic-coated control Ig or anti-CD3 mAb for 2 min. The cells were stimulated or
not with pervanadate for 10 min at 378C and lysed in the 1% digitonin buffer. The lysates were immunoprecipitated with anti-CD18 mAb or
control Ig and analyzed by immunoblotting with anti-DNAM-1 mAb. DNAM-1 was coimmunoprecipitated with LFA-1 in T cells activated by
anti-CD3, but not in resting T cells, regardless of the stimulation with pervanadate.
isolated NK cells (Figure 2), suggesting a constitutive (WT) DNAM-1 cDNA or a site-directed mutant of DNAM-1
at S329 (S-F329), both tagged with the FLAG peptide epi-associate of DNAM-1 and LFA-1 in these cell types. Our
prior findings that activated PKC phosphorylates the tope at the N terminus. The transfectants were examined
for the association of LFA-1 with endogenous and trans-serine at residue 329 in the cytoplasmic domain of
DNAM-1 and increases avidity of DNAM-1-mediated ad- fected DNAM-1 molecules. Figure 4B shows that anti-
LFA-1 coimmunoprecipitated both endogenous andhesion with cells bearing its ligand (Shibuya et al., 1998)
suggested that phosphorylated S329 may be involved transfected wild-type DNAM-1. By contrast, the mutant
S-F329 DNAM-1 glycoprotein was not coimmunoprecipi-in the association of DNAM-1 with LFA-1. To test this
hypothesis, Jurkat cells were transfected with wild-type tated with LFA-1. To confirm the phosphorylation of S329
of DNAM-1, the Jurkat transfectants were metabolically
labeled with [32P]orthophosphate and DNAM-1 proteins
were immunoprecipitated with anti-FLAG mAb. As
shown in Figure 4C, the DNAM-1 proteins in Jurkat cells
transfected with WT DNAM-1, but not with S-F329 mutant
DNAM-1, were phosphorylated, consistent with the con-
clusion that LFA-1 associates with wild-type DNAM-1,
but not with S-F329 mutant DNAM-1. These results indi-
cate that phosphorylated S329 plays a critical role in the
association of LFA-1 with DNAM-1.
Cross-Linking of LFA-1 Induces TyrosineFigure 4. Role of Ser329 of DNAM-1 in the Association of DNAM-1
Phosphorylation of DNAM-1 and Fynwith LFA-1
in Activated T Cells(A) Jurkat cells and NKL cells were lysed in the 1% digitonin lysis
Because the cytoplasmic domain of DNAM-1 containsbuffer and immunoprecipitated with anti-DNAM-1 mAb, anti-CD18
mAb, or cIg. The immunoprecipitates were analyzed by immunoblot- tyrosines that are phosphorylated by stimulation with
ting with anti-DNAM-1 mAb. DNAM-1 was coimmunoprecipitated pervanadate in T cells and NK cells (data not shown), we
with CD18 in Jurkat and NKL cells. examined whether directly cross-linking LFA-1 induces
(B) Jurkat cells were transfected with wild-type (WT) or site-directed tyrosine phosphorylation of DNAM-1. Figure 5A demon-
mutant (S-F329) DNAM-1, both tagged with the FLAG epitope. The
strates that ligation of LFA-1 with anti-CD18 mAb signifi-transfectants were lysed in the 1% digitonin buffer and immunopre-
cantly induced tyrosine phosphorylation of DNAM-1 incipitated with anti-CD18 mAb or control Ig. The immunoprecipitates
were analyzed by immunoblotting with anti-DNAM-1 mAb or anti- anti-CD3 activated T cells, whereas it did not induce the
FLAG mAb. CD18 was coimmunoprecipitated with wild-type DNAM-1, phosphorylation of DNAM-1 in resting, nonstimulated T
but not with S-F329 DNAM-1. cells, where LFA-1 is not associated with DNAM-1 (Fig-
(C) Jurkat transfectants with wild-type or site-directed mutant ure 3A). It should be noted that low levels of tyrosine-
(S-F329) DNAM-1 were metabolically labeled with [32P]orthophos-
phosphorylated DNAM-1 were also detected in T cellsphate and DNAM-1 proteins were immunoprecipitated with anti-
activated with anti-CD3 mAb alone (Figure 5A), possiblyFLAG mAb. The DNAM-1 proteins in Jurkat cells transfected with WT
DNAM-1, but not with S-F329 mutant DNAM-1, were phosphorylated. because the activated T cells expressed not only LFA-1,
Association of LFA-1 and DNAM-1
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Figure 5. Relationship between LFA-1, DNAM-1, and the Protein Tyrosine Kinase Fyn
(A) Resting peripheral blood T cells were stimulated with plastic-coated cIg, anti-CD3 mAb, and/or anti-CD18 mAb for 2 min. The cells were
then lysed in the 1% NP-40 buffer and immunoprecipitated with cIg, anti-protein tyrosine kinases Lck, Fyn, or anti-DNAM-1 mAb. The
immunoprecipitates were immunoblotted with anti-phosphotyrosine mAb 4G10. Tyrosine phosphorylation of Fyn and DNAM-1 was augmented
by the stimulation with anti-CD18 in the combination with anti-CD3, but not by cross-linking with anti-CD18 alone.
(B) Resting peripheral blood T cells were stimulated with plastic-coated cIg or anti-CD3 mAb for 2 min. Then the cells were stimulated or not
with pervanadate for 10 min at 378C and lysed in 1% digitonin buffer. The lysates were immunoprecipitated with cIg, anti-CD18 or anti-DNAM-1
and analyzed by immunoblotting with anti-Fyn. Fyn was coimmunoprecipitated with DNAM-1, but not with CD18, in T cells stimulated with
pervanadate alone. Co-immunoprecipitation of Fyn with CD18 was always detected in T cells stimulated with anti-CD3 mAb.
but also its ligand ICAM-1. These results suggest that with DNAM-1 rather than LFA-1, although we cannot
exclude intermediate adaptor molecules in the process.cross-linking of LFA-1 with antibody or possibly with its
ligand results in tyrosine phosphorylation of DNAM-1 in
activated T cells. Fyn Phosphorylates Y322 of DNAM-1
These results led us to search for the protein tyrosine To determine the site of phosphorylated tyrosine in the
kinases (PTK) involved in the phosphorylation of DNAM-1. DNAM-1 cytoplasmic domain, Jurkat cells were trans-
The amino acid sequence REDIY322VNY in the cyto- fected with WT or a site-directed mutant (Y-F322)
plasmic domain of DNAM-1 is a possible phosphoryla- DNAM-1, both tagged with FLAG at the N terminus.
tion site for a Src family PTK (Shibuya et al., 1996). These transfectants were stimulated with pervanadate
Therefore, we looked for a Src family PTK expressed in and the FLAG-tagged wild-type, and Y-F322 DNAM-1 pro-
T cells that was phosphorylated in response to cross- teins were immunoprecipitated with anti-FLAG mAb and
linking of LFA-1. No PTK tested was phosphorylated by then immunoblotted with anti-phosphotyrosine or anti-
anti-LFA-1 ligation using resting, nonstimulated T cells Fyn. Figure 6 shows that phosphorylated tyrosines were
(Figure 5A and not shown). Stimulation of resting T cells detected in wild-type FLAG-tagged DNAM-1, but not in
with anti-CD3 mAb alone induced tyrosine phosphoryla- Y-F322 DNAM-1, indicating that Y322 of DNAM-1 is the site
tion of Lck and Fyn, consistent with the previous reports phosphorylated in response to pervanadate stimulation.
that these PTK are regulated by the CD3/TcR complex Of note, Fyn was coimmunoprecipitated with both wild-
(Samelson et al., 1990; Iwashima et al., 1994). However, type and Y-F322 mutant DNAM-1 protein, suggesting that
coligation of both LFA-1 and CD3 induced or augmented Fyn may phosphorylate the Y322 of DNAM-1.
tyrosine phosphorylation of Fyn, but not of Lck, implicat-
ing the Fyn protein tyrosine kinase in the activation
process.
DNAM-1 Binds Fyn
To address the relationship of Fyn with LFA-1 and
DNAM-1, resting T cells were stimulated with anti-CD3
and/or pervanadate, lysed, and immunoprecipitated
with either anti-CD18 or anti-DNAM-1. As shown in Fig-
ure 5B, Fyn was coimmunoprecipitated with DNAM-1, Figure 6. Y322 Is Required for Pervanadate-Induced Phosphorylation
but not with CD18, in T cells treated with pervanadate, of DNAM-1
indicating that Fyn is primarily recruited by DNAM-1, Jurkat cells were transfected with wild-type or site-directed mutant
Y-F322 DNAM-1, both tagged with the FLAG epitope. Two days afterbut not LFA-1. Fyn was also coimmunoprecipitated with
transfection, Jurkat cells were stimulated with pervanadate for 10DNAM-1 from T cells activated by anti-CD3 (Figure 5B),
min at 378C and lysed in 1% NP-40 buffer (left) or 1% digitoninconsistent with the results that tyrosine phosphorylation
buffer (right). The lysates were immunoprecipitated with anti-FLAGof Fyn was induced by anti-CD3 stimulation alone (Fig-
or cIg and analyzed by immunoblotting with anti-phosphotyrosine
ure 5A). Because Fyn was coimmunoprecipitated with (4G10) or anti-Fyn. Wild-type DNAM-1, but not Y-F322 DNAM-1, was
LFA-1 only under conditions that induced association tyrosine phosphorylated (left). Fyn was coimmunoprecipitated with
both wild-type and Y-F322 DNAM-1.of LFA-1 and DNAM-1, this kinase is likely interacting
Immunity
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cytotoxicity function by cross-linking the DNAM-1 re-
ceptor requires tyrosine phosphorylation of DNAM-1 in-
duced by Fyn, which is activated by LFA-1. Further stud-
ies using a genetic reconstitution model will be required
to determine whether Fyn is involved in the function of
DNAM-1 receptor.
The signaling pathways involved in LFA-1 function
are complex and incompletely understood. Prior studies
have demonstrated that the LFA-1-mediated cell adhe-
sion is enhanced in T cells after stimulation of the TCR
or upon activation of PKC by phorbol esters (Dustin
and Springer, 1989; van Kooyk et al., 1989). We have
Figure 7. Fyn Is Responsible for Tyrosine Phophorylation of previously reported that PKC activation by PMA also
DNAM-1 increases ligand binding activity of DNAM-1 (Shibuya et
COS 7 cells were cotransfected with wild-type or T-F322 mutant al., 1998). In this study, we have shown that, under these
DNAM-1 and either with wild-type, kinase dead, or constitutively
conditions that activate T cells, these adhesion mole-active fyn. Two days after transfection, DNAM-1 proteins were im-
cules form a physical complex. At present, it is uncertainmunoblotted with anti-phosphotyrosine. The wild-type DNAM-1
how adhesion and intracellular signaling are mediatedprotein was tyrosine phosphorylated in the cotransfectant with wild-
type and constitutively active, but not kinase dead, fyn. By contrast, by the complex of LFA-1 and DNAM-1 regulated follow-
the tyrosine phopshorylation of Y-F322 mutant DNAM-1 was not de- ing activation of T cells. To address this issue, it is
tected in the transfectant with any type of fyn (right). essentially required to identify the DNAM-1 ligand and
determine the structural requirement involved in DNAM-1
binding.To examine whether Fyn is responsible for phosphory-
There are evidences that b1 (a1b1 and a5b1) and b3lation of the tyrosine at residue 322 of DNAM-1, COS-7
(aIIbb3 and aVb3) integrins associate with a membranecells were cotransfected with wild-type or T-F322 mutant
adaptor molecule caveolin-1 (Wary et al., 1998) andDNAM-1 and either with wild-type, kinase dead, or con-
CD47 (Lindberg et al., 1993), respectively. Our studiesstitutively active fyn, and DNAM-1 proteins were immu-
indicate the physical and functional association ofnoblotted with anti-phosphotyrosine. As demonstrated
DNAM-1 with aLb2 integrin LFA-1. Many signal-trans-
in Figure 7, the wild-type DNAM-1 was tyrosine phos-
ducing molecules are also involed in LFA-1 function.
phorylated in the transfectant with wild-type and consti-
For example, cross-linking of LFA-1 by antibodies or
tutively active, but not kinase dead, fyn. By contrast, potentially by ligand results in the activation of protein
the tyrosine phopshorylation of Y-F322 mutant DNAM-1 tyrosine kinases in T cells or NK cells (Sugie et al., 1995;
was not detected in the transfectant with any type of Kanner, 1996; Rodriguez-Fernandez et al., 1999), and
fyn. These results indicate that Fyn is likely a responsible the stimulation of PLC-g1 (Kanner et al., 1993), and there
kinase for phosphorylation of Y322 of DNAM-1. is evidence for coimmunoprecipitation of LFA-1 with
ZAP70 (Soede et al., 1998) and with cytohesin (Kolanus
Discussion et al., 1996) in activated T cells. In addition, coclustering
has been demonstrated for the LFA-1-FcgRIIIb pair
In this study, we demonstrate that initiation of cytotoxic- on neutrophils (Zhou et al., 1993). Furthermore, LFA-1-
ity function by cross-linking the DNAM-1 receptor is dependent activation results in translocation of PKC to
dependent upon a functional interaction with LFA-1. Ge- the cytoskeleton in T cells (Volkov et al., 1998). Further
netic restoration of LFA-1 expression in NK cells estab- studies will be required to determine the relationship of
lished from a LAD patient rendered the DNAM-1 mole- these signal-transducing molecules with DNAM-1 and
cule functional, thus providing formal evidence for this Fyn to elucidate the role of these molecules in LFA-1
association. This observation prompted further studies function.
to understand the molecular basis for this phenomenon.
We have shown that LFA-1 physically associates with Experimental Procedures
DNAM-1 in normal peripheral NK cells. Moreover, stimu-
Cells and Reagentslation of resting T cells with either anti-CD3 or PMA
Resting T cells were isolated from the peripheral blood of healthyinduces the association of LFA-1 and DNAM-1 and this
volunteers, as described previously (Azuma et al., 1992). Resting
requires phosphorylation of S329 in DNAM-1. Presently, CD3-CD561 NK cells (CD3-CD561) were purified by cell sorting
it is uncertain whether this reflects a direct interaction using flow cytometry from the peripheral blood of healthy volunteers.
NK clones were established from the peripheral blood of healthyor an indirect association via adaptor molecules or the
donors or a patient with leukocyte adhesion molecule deficiencycytoskeleton. Nonetheless, once LFA-1 and DNAM-1
using the culture conditions described previously (Yssel et al., 1984)associate, cross-linking LFA-1 results in the tyrosine
and 100 IU/ml recombinant IL-2 as a growth factor. Jurkat is a
phosphorylation of DNAM-1. DNAM-1 phosphorylation human T cell leukemia cell line. NKL is a human NK leukemia cell
on tyrosine was not induced by cross-linking DNAM-1 line generously provided by Dr. Mike Robertson (University of India-
napolis) (Robertson et al., 1996). P815 is a murine mastocytomawith mAb but requires the ligand binding of LFA-1 (Fig-
cell line. PMA was purchased from Sigma (St. Louis, Missouri) andure 1C and our unpublished data). We have demon-
dissolved in DMSO, which did not exceed 0.1% in the assay medium.strated that cross-linking LFA-1 also augmented tyro-
sine phosphorylation of Fyn, and this kinase is likely Abs and Flow Cytometry
responsible for DNAM-1 phosphorylation at residue 322. Control IgG, anti-CD3 (Leu 4 mAb), anti-CD16 (Leu 11a mAb), anti-
CD11a (L7 mAb), anti-CD11b (Leu 15 mAb), anti-CD11c (Leu M5Taken together, these results suggest that initiation of
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mAb), anti-CD56 (Leu 19 mAb), and anti-CD18 (L130 mAb) were 20 mM triethanolamine (Katayama Pure Chemical), protease inhibi-
tors (1 mM PMSF and 20 Kallikrein inhibitor U/ml aprotinin), andgenerously provided by Becton Dickinson Immunocytometry Sys-
tems (San Jose, California). Anti-DNAM-1 mAb (DX11) were gener- phosphatase inhibitors (1 mM EGTA, 10 mM NaF, 1 mM Na4PO7,
0.1 mM b-glycerophosphatase, 1 mM Na3VO4). The lysates wereated as described (Shibuya et al., 1996). Anti-phosphotyrosine mAb
(4G10) was purchased from Upstate Biotechnology Inc., Lake immunoprecipitated with anti-CD18, anti-DNAM-1 (DX11 mAb), anti-
FLAG, or control Ig, and proteins were separated by SDS-PAGE.Placid, New York. Anti-FLAG mAb was purchased from Sigma. Anti±
protein tyrosine kinases Lck and Fyn are polyclonal rabbit Abs that Immunoprecipitates were transferred (100V, 1 hr in 25 mM Tris, 195
mM glycine, 20% methanol) to PVDF membranes (Immobilon-P,were gifts from Dr. Joe Bolen (DNAX). F(ab9)2 fragments of anti-
CD18 were prepared as described (Shibuya et al., 1996). Purity of Millipore). Membranes were incubated overnight in Tris-buffered
saline (TBST) containing 0.5% Tween 20, MgCl2, and 3% BSA atthe F(ab9)2 fragments was determined by SDS-PAGE. Methods of
immunofluorescent staining and flow cytometry have been de- 48C, and then incubated with primary antibodies (1 mg/ml in TBST
with 3% BSA) for 2 hr at room temperature. Proteins were detectedscribed previously (Lanier and Recktenwald, 1991).
by using HRP-conjugated goat anti-mouse or anti-rabbit Ig (Amer-
sham, Arlington Heights, IL) and developed with SuperSignal CL-Cytotoxicity Assay
HRP Substrate (Pierce, Rockford, IL). Chemiluminescence was de-Tumor cell lines (z1.5 3 106 cells) were labeled with 100 mCi 51Cr
tected by autoradiograph.for 2 hr, washed, and used as targets in a 4-h radioisotope release
To examine tyrosine phosphorylation of DNAM-1, cells were stim-cytotoxicity assay, as described (Lanier et al., 1983). Data are ex-
ulated or not with plastic-precoated mAbs for 2 min and/or 100 mMpressed as the means of triplicate cultures. Spontaneous radioiso-
sodium pervanadate for 10 min at 378C. Cells were lysed in Tris-tope release was typically ,10% of total 51Cr release. Percent cytoly-
buffered saline (50 mM Tris, 150 mM NaCl, pH 8.0) containing 1%sis was calculated as:
NP-40 and the protease and phosphatase inhibitors described above.
Cell lysates were immunoprecipitated with control Ig, anti-DNAM-1cpm specific 51Cr release 2 cpm spontaneous release
cpm total 51Cr release 2 cpm spontaneous release
3100 mAb (DX11), anti-FLAG or anti-PTKs Lck or Fyn and proteins were
separated by SDS-PAGE. Immunoprecipitates were immunoblotted,
as described above, and then incubated with anti-phosphotyrosine
Genetic Reconstitution of LAD NK Cell Clones 4G10 (1 mg/ml in TBST with 3% BSA) for 2 hr at room temperature.
A cDNA containing the open reading frame of CD18 was generated Proteins were detected by using HRP-conjugated goat anti-mouse Ig.
by PCR using a wild-type CD18 cDNA plasmid as the template. The For the analysis of tyrosine phosphorylation of DNAM-1 induced
PCR products were subcloned into a retroviral vector pMX-neo by mAbs and P815 cells, P815 cells were precoated with control Ig
(Onishi et al., 1996) (kindly provided by Toshio Kitamura, DNAX) with or anti-DNAM-1 (DX11 mAb) and then incubated with NK clones
cloning sites of BamH1 (59) and Not1 (39). Phoenix-amphotropic derived from a LAD patient, as described previously (Shibuya et al.,
packaging cells (Kinsella and Nolan, 1996) (generously provided by 1996).
Gary Nolan, Stanford) were transfected with the CD18 cDNA in the
retroviral vector using lipofectamine (GIBCO-BRL), as described
Acknowledgmentspreviously (Kitamura et al., 1995; Onishi et al., 1996). LAD NK clones
were infected with the CD18 retrovirus stock. Two days after infec-
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Reiko Shimamura for expert assistance with flow cytometry, andand CD11c were analyzed by flow cytometry.
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were designed. The PCR products were subcloned into the pFLAG-
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